Details for New Drug Application (NDA): 022290
✉ Email this page to a colleague
The generic ingredient in ADREVIEW is iobenguane sulfate i-123. One supplier is listed for this compound. Additional details are available on the iobenguane sulfate i-123 profile page.
Summary for 022290
Tradename: | ADREVIEW |
Applicant: | Ge Healthcare |
Ingredient: | iobenguane sulfate i-123 |
Patents: | 0 |
Suppliers and Packaging for NDA: 022290
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADREVIEW | iobenguane sulfate i-123 | SOLUTION;INTRAVENOUS | 022290 | NDA | Medi-Physics Inc. | 17156-235 | 17156-235-01 | 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10mCi/5ML (2mCi/ML) | ||||
Approval Date: | Sep 19, 2008 | TE: | RLD: | Yes |
Complete Access Available with Subscription